0001209191-24-001042.txt : 20240105
0001209191-24-001042.hdr.sgml : 20240105
20240105164151
ACCESSION NUMBER: 0001209191-24-001042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burgess Julie
CENTRAL INDEX KEY: 0001883722
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40288
FILM NUMBER: 24516811
MAIL ADDRESS:
STREET 1: C/O DESIGN THERAPEUTICS, INC.
STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Design Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823929248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
BUSINESS PHONE: 858-293-4900
MAIL ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-02
0
0001807120
Design Therapeutics, Inc.
DSGN
0001883722
Burgess Julie
C/O DESIGN THERAPEUTICS, INC.
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD
CA
92011
0
1
0
0
Chief Accounting Officer
0
Stock Option (right to buy)
2.54
2024-01-02
4
A
0
110000
0.00
A
2034-01-01
Common Stock
110000
110000
D
The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.
/s/ Mustapha Parekh, Attorney-in-Fact
2024-01-05